Giananthony Rizzo[email protected]Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 2In the second part of our series on the coming shortage of SPECT radiopharmaceuticals, Giananthony Rizzo of Decision Resources Group examines other factors in the U.S. healthcare industry that could affect isotope prices in the future.November 17, 2016Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 1A perfect storm is brewing in the global SPECT market that could see the prices of radiopharmaceuticals skyrocket over the next five years. A number of factors are coalescing that could lead to a shortage of SPECT tracers for years to come, according to this article by Giananthony Rizzo of Decision Resources Group.November 16, 2016Page 1 of 1Top StoriesMRIAI-powered MRI technique maps brain fluid flow tied to Alzheimer'sA physics-informed AI framework reveals 3D fluid velocity pathways across the entire living brain using standard MRI data.CTFat deposits found on pre-pandemic CT exams predict COVID-19 severitySNMMI 2026SNMMI annual meeting puts science in the spotlightUltrasoundCEUS shows promise in patients with Fontan-associated liver diseaseSponsor ContentThe Wedding Was Easy. The Marriage Is the Work.
